Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

A trial is testing how the body absorbs kaempferol, a plant compound

Recruiting · University of Pittsburgh

What this means

Healthy adults will take kaempferol and give blood and urine samples over a short time. The trial has not reported results, so it cannot yet tell us how well the body absorbs it or what it does.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 18–70
Where
3 sites, including New York, North Carolina, Pennsylvania

Contacts and how to join ↗

The science

Registered title
Kaempferol Absorption and Pharmacokinetics Evaluation
Phase
Not applicable
Study type
interventional
Conditions
No Disease, Mitochondria Health, Longevity, Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult, Healthy Volunteers
What is tested
Kaempferol
Sponsor
University of Pittsburgh
Ages
18 Years to 70 Years
Dates
First posted Jan 7, 2026 · updated Mar 23, 2026

Registry summary

This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults.

Participants will receive Kaempferol and undergo scheduled blood and urine collections over a short study period. These samples will be used to measure Kaempferol levels in the body and to assess safety and tolerability. In addition, selected biological samples will be analyzed to explore molecular changes associated with Kaempferol exposure using advanced laboratory methods.

The study will be conducted at multiple research centers in the United States using a standardized protocol to ensure consistency across sites. The information collected will help improve understanding of how Kaempferol is absorbed and metabolized in humans and will support future research and regulatory evaluation.

Sites (3)

  • Weill Cornell Medicine, New York, New York, United States
  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States

More aging trials in these states

New York · North Carolina · Pennsylvania

Report a problem